Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Lumacaftor by Qanatpharma for Congestive Heart Failure (Heart Failure): Likelihood of Approval
Lumacaftor is under clinical development by Qanatpharma and currently in Phase II for Congestive Heart Failure (Heart Failure). According to...
Data Insights
Lumacaftor by Qanatpharma for Subarachnoid Hemorrhage: Likelihood of Approval
Lumacaftor is under clinical development by Qanatpharma and currently in Phase II for Subarachnoid Hemorrhage. According to GlobalData, Phase II...